Article
Author(s):
Smaller entrepreneurial pharmacy owners are proactively pursuing the dispensing of specialty medications.
To calculate cost of dispensing a prescription, take total annual costs allocated to the prescription department divided by the annual number of prescriptions dispensed. Sounds pretty simple right?
It’s a tried and true calculation that works great for prescriptions routinely filled by a community pharmacy. We all know to include all the obvious direct costs such as vials and labels, as well as indirect costs such as rent, insurance, marketing, etc.
I recently tried to analyze true cost of dispensing for our specialty pharmacy, which resides inside one of our community pharmacies. As you can imagine, there are multiple points of cross-sharing in many aspects of the business.
Determining the true cost analysis of each practice is important, so this cross-sharing poses a great challenge. In the beginning of my analysis, I thought I would just calculate the square footage, calculate number of hours worked, and divide the number of prescriptions filled by each into that calculation.
It was during this exercise that I discovered just how much cost is involved in the dispensing process of a specialty drug. I have had numerous independent community pharmacists ask me about our specialty practice. Most of those folks have a community pharmacy and want to implement specialty drugs into it.
This article may help pharmacists answer the question of whether to do it or not. It may also help pharmacists who are filling specialty prescriptions to determine a more accurate allocation of expenses or, perhaps, discover expenses they didn’t know existed. To this point, I’m sharing what I’ve learned about finding these hidden costs and including them in our analysis of finding out our true cost for dispensing a specialty product.
According to the 2018-19 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors, independent pharmacies are expanding into specialty drug dispensing.1 Smaller entrepreneurial pharmacy owners are proactively pursuing the dispensing of specialty medications. Thirty-nine percent of independent community pharmacies dispense specialty medications. Numerous fast-growing independent pharmacies have transitioned their businesses into a specialty pharmacy focus.1
The report found that independents accounted for about one-sixth of the pharmacy industry’s revenues, but equal more than one-third of all pharmacy locations. The report also estimates that by 2022, 47% of the pharmacy industry’s revenues will come from specialty drugs.1 In 2017, it was estimated that specialty drugs accounted for approximately one-third of the industry’s total prescription dispensing revenues.
If you read the National Community Pharmacist Association Digest, you will see that your geographical location will influence your business cost and revenues.2 We are located in Austin, Texas, and our community pharmacy has been in the neighborhood for 61 years. The specialty practice, which was established in 2015, currently occupies approximately one-third of the building and has dedicated staff, technology, and inventory.
If you are new to specialty or you are trying to determine exactly what a specialty drug is, I must warn you that everyone has their opinion.
PBM Model Definition of a Specialty Drug
A prescription medication shall be designated as a specialty drug when it cannot be routinely dispensed at a majority of retail community pharmacies and it meets a majority of the following criteria:
State Medicaid programs have similar definition of what a specialty drug is, so next we attempt to define what a specialty pharmacy is. A specialty pharmacy is a state licensed pharmacy that dispenses specialty prescriptions for people with serious health conditions requiring complex therapies.
These conditions include, but are not limited to, cancer, hepatitis C, rheumatoid arthritis, HIV/AIDS, multiple sclerosis, cystic fibrosis, organ transplantation, human growth hormone deficiencies, and hemophilia and other bleeding disorders. In addition to being state licensed and regulated, specialty pharmacies should facilitate education and coordination with prescribers and payers, and have clinical review and drug utilization protocols in place, provide patient care services and a comprehensive patient management program, have a support program for patients facing reimbursement challenges, and be accredited by an independent third party.
We started our specialty practice from ground zero, the slow and steady growth allowed us to transition into many of the high touch activities that we now provide on a larger scale. We incorporated these activities without really realizing what they were going to cost in the future (on a larger scale).
These are hard to track but are specific and necessary to the dispensing process of specialty products. I think it is important that pharmacists going into this practice have an awareness of the amount of time and “extras” that it takes to accept, research, fill, and follow through on patient counseling, and then follow up at the completion of therapy for dispensing of most specialty products.
Across the industry, the average time it takes for a patient to receive their specialty medication after it is prescribed is 3 to 6 weeks. This statistic demonstrates the intensity of the fill process. Going through the exercise of measuring actual time required to fill a specialty prescription brings attention and heightens awareness of the cost. This is very helpful when trying to calculate the true return on investment of staff time. It takes us over 2 hours to refill a specialty prescription.
We definitely operate at a much higher level of customer touch and 1-on-1 service with specialty patients versus community pharmacy patients. There are numerous services, tasks and equipment involved in dispensing specialty drugs. Below is a list that may help raise awareness and discovery of what is needed.
The list may also serve to assist in the allocation of expenses that may have been overlooked or erroneously calculated in the past. This list is not inclusive and doesn’t include requirements you will need for intravenous specialty products.
Costs to be considered for allocation to specialty practice
Accreditation, certification and training
Education for staff
Patient care services, counseling, and training
Tracking and reporting patient adherence and outcomes
Storage, handling, and delivery
Reimbursement requirements
Website
Computer software and additional specialty software
Refrigeration and temperature controls
Staffing
Other
Any administration supplies you furnish at no charge
Line of credit
Professional memberships beyond what you may have now
Works Cited
1. 2018-19 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Adam J. Fein, PhD. Drug Channels Institute - October 2018
2. 2018 NCPA Digest
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa